| Literature DB >> 33912115 |
Jarkko Jalava1, Stephanie Griffiths2,3, Rasmus Rosenberg Larsen4, B Emma Alcott5.
Abstract
Questionable research practices are a well-recognized problem in psychology. Coding bias, or the tendency of review studies to disproportionately cite positive findings from original research, has received comparatively little attention. Coding bias is more likely to occur when original research, such as neuroimaging, includes large numbers of effects, and is most concerning in applied contexts. We evaluated coding bias in reviews of structural magnetic resonance imaging (sMRI) studies of PCL-R psychopathy. We used PRISMA guidelines to locate all relevant original sMRI studies and reviews. The proportion of null-findings cited in reviews was significantly lower than those reported in original research, indicating coding bias. Coding bias was not affected by publication date or review design. Reviews recommending forensic applications-such as treatment amenability or reduced criminal responsibility-were no more accurate than purely theoretical reviews. Coding bias may have contributed to a perception that structural brain abnormalities in psychopaths are more consistent than they actually are, and by extension that sMRI findings are suitable for forensic application. We discuss possible sources for the pervasive coding bias we observed, and we provide recommendations to counteract this bias in review studies. Until coding bias is addressed, we argue that this literature should not inform conclusions about psychopaths' neurobiology, especially in forensic contexts.Entities:
Keywords: PCL-R; coding bias; psychopath; review studies; sMRI; systematic review
Year: 2021 PMID: 33912115 PMCID: PMC8071952 DOI: 10.3389/fpsyg.2021.654336
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1PRISMA flow charts.
Summary of sMRI effects.
| Raine et al. ( | Introduction and results text, tables | Multivariate statistical controls for drug use | 4 | 50% (2) | 50% (2) |
| Laakso et al. ( | Introduction and results text, tables | Hippocampal slices at 5% volume intervals; Bonferroni correction of p-values reported for PCL-R Total score-volume correlations | 40 | 5% (2) | 95% (38) |
| Laakso et al. ( | Introduction and results text, tables | Group design to control for drug use | 10 | 0% (0) | 100% (10) |
| Raine et al. ( | Introduction and results text, tables | MANCOVA for confounds | 5 | 60% (3) | 40% (2) |
| Raine et al. ( | Introduction and results text, tables | Bonferroni correction for multiple comparisons | 6 | 33.33% (2) | 66.67% (4) |
| Yang et al. ( | Introduction and results text, tables | Statistical control (ANOVA) for confounds | 6 | 33.33% (2) | 66.67% (4) |
| Schiltz et al. ( | Introduction and results text | Voxel-wise thresholding ( | 1 | 0% (0) | 100% (1) |
| de Oliveira-Souza et al. ( | Introduction and results text, tables | FDR ( | 18 | 22.22% (4) | 77.78% (14) |
| Müller et al. ( | Introduction and results text, tables | Corrected for multiple comparisons across all ROIs | 12 | 8.33% (1) | 91.67% (11) |
| Tiihonen et al. ( | Introduction, results, and discussion text, tables | FDR ( | 66 | 56.06% (37) | 43.94% (29) |
| Craig et al. ( | Results text, tables | Bonferroni correction for multiple comparisons (stream lines and FA) | 4 | 25% (1) | 75% (3) |
| Yang et al. ( | Text | Permutation corrected | 4 | 50% (2) | 50% (2) |
| Yang et al. ( | Text | Permutation corrected | 4 | 100% (4) | 0% (0) |
| Yang et al. ( | Introduction and results text, tables | Multivariate correction for confounds | 48 | 16.67% (8) | 83.33% (40) |
| Boccardi et al. ( | Introduction and results text, tables | Permutation corrected | 12 | 25% (3) | 75% (9) |
| Glenn et al. ( | Introduction and results text | Multivariate statistical control for confounds | 7 | 42.86% (3) | 57.14% (4) |
| Glenn et al. ( | Introduction and results text | Multivariate statistical control for confounds | 3 | 0% (0) | 100% (3) |
| Raine et al. ( | Results text | Multivariate correction for confounds | 1 | 100% (1) | 0% (0) |
| Boccardi et al. ( | Introduction, results, and discussion text, tables, Supplementary materials | Results taken as reported by authors in supplementary tables (40 ROIs for all pair-wise comparisons of three groups) | 312 | 41.67% (130) | 58.33% (182) |
| Motzkin et al. ( | Results text | Group comparison for single structure | 2 | 50% (1) | 50% (1) |
| Schiffer et al. ( | Introduction and results text, tables | FDR ( | 8 | 62.5% (5) | 37.5% (3) |
| Yang et al. ( | Introduction and results text | Permutation corrected | 4 | 75% (3) | 25% (1) |
| Cope et al. ( | Introduction and results text, tables | Small volume correction, FWE ( | 26 | 3.85% (1) | 96.15% (25) |
| Ermer et al. ( | Introduction and results text, tables | FDR correction for peak height analyses and cluster extent analyses | 60 | 20% (12) | 80% (48) |
| Gregory et al. ( | Introduction and results text, tables | FDR correction for cluster extent analyses, controlling for confounds | 20 | 20% (4) | 80% (16) |
| Howner et al. ( | Introduction and results text, tables | FDR correction for thickness maps | 11 | 27.27% (3) | 72.73% (8) |
| Ly et al. ( | Introduction and results text, tables | Cluster extent thresholding (uncorrected | 13 | 100% (13) | 0% (0) |
| Boccardi et al. ( | Introduction and results text, tables | Permutation corrected | 18 | 16.67% (3) | 83.33% (15) |
| Pujara et al. ( | Introduction and results text | Tissue segmentation | 8 | 0% (0) | 100% (8) |
| Sethi et al. ( | Introduction and results text, tables | Statistical control for confounds ANOVA | 4 | 25% (1) | 75% (3) |
| Wolf et al. ( | Introduction and results text | Multivariate control for confounds | 2 | 50% (1) | 50% (1) |
| Contreras-Rodríguez et al. ( | Introduction and results text, Supplementary tables | FWE correction ( | 19 | 100% (19) | 0% (0) |
| Korponay et al. ( | Introduction and results text, tables | Peak height FWE correction ( | 7 | 14.29% (1) | 85.71% (6) |
| Korponay et al. ( | Introduction and results text, supplementary text and tables | Small volume correction | 8 | 62.5% (5) | 37.5% (3) |
| Lam et al. ( | Introduction and results text, tables | Multivariate correction for multiple comparisons | 12 | 33.33% (4) | 66.67% (8) |
| Crooks et al. ( | Introduction and results text, tables | Spearman's rho; partial correlations (to control for confounds) | 1 | 100% (1) | 0% (0) |
| Miskovich et al. ( | Introduction and results text | Cluster correction for multiple comparisons ( | 4 | 50% (2) | 50% (2) |
| Crooks et al. ( | Introduction and results text, tables | Spearman's rho; partial correlations and regression (to control for confounds) | 1 | 0% (0) | 100% (1) |
| Total | 791 | 35.90% (284) | 64.1% (507) | ||
Summary of review study effects.
| Bassarath ( | N | Laakso et al. ( | 100% (2/2) | 0% (0/2) | N |
| Blair ( | E | Raine et al. ( | 50% (1/2) | 50% (1/2) | N |
| Pridmore et al. ( | N | Raine et al. ( | 57% (4/7) | 43% (3/7) | N |
| Anckarsäter ( | N | Laakso et al. ( | 80% (4/5) | 20% (1/5) | N |
| Kiehl ( | T | Laakso et al. ( | 100% (2/2) | 0% (0/2) | N |
| Raine and Yang ( | N | Raine et al. ( | 100% (7/7) | 0% (0/7) | Y |
| Raine and Yang ( | N | Raine et al. ( | 73% (8/11) | 27% (3/11) | Y |
| Herba et al. ( | T | Laakso et al. ( | 50% (5/10) | 50% (5/10) | N |
| Glenn and Raine ( | N | Raine et al. ( | 100% (4/4) | 0% (0/4) | N |
| Weber et al. ( | N | Raine et al. ( | 64% (9/14) | 36% (5/14) | Y |
| Yang et al. ( | N | Laakso et al. ( | 100% (6/6) | 0% (0/6) | Y |
| Gao et al. ( | N | Raine et al. ( | 82% (9/11) | 18% (2/11) | N |
| Plodowski et al. ( | N | Raine et al. ( | 54% (21/39) | 46% (18/39) | N |
| Wahlund and Kristiansson ( | T | Laakso et al. ( | 89% (8/9) | 11% (1/9) | N |
| Yang and Raine ( | M | Laakso et al. ( | 100% (2/2) | 0% (0/2) | N |
| Blair ( | T | Yang et al. ( | 100% (14/14) | 0% (0/14) | N |
| Muller ( | N | Tiihonen et al. ( | 80% (16/20) | 20% (4/20) | N |
| Koenigs et al. ( | N | Yang et al. ( | 89% (17/19) | 11% (2/19) | N |
| Anderson and Kiehl ( | N | Ermer et al. ( | 100% (27/27) | 0% (0/27) | Y |
| Koenigs ( | T | Yang et al. ( | 90% (9/10) | 10% (1/10) | N |
| Blair ( | T | Ermer et al. ( | 100% (14/14) | 0% (0/14) | N |
| Loomans et al. ( | N | Raine et al. ( | 92% (22/24) | 8% (2/24) | N |
| Anderson and Kiehl ( | N | Ermer et al. ( | 100% (16/16) | 0% (0/16) | Y |
| Anderson and Kiehl ( | N | Boccardi et al. ( | 100% (11/11) | 0% (0/11) | N |
| Aoki et al. ( | M | de Oliveira-Souza et al. ( | 100% (3/3) | 0% (0/3) | N |
| Debowska et al. ( | N | Yang et al. ( | 88% (22/25) | 12% (3/25) | N |
| Glenn and Raine ( | N | Yang et al. ( | 96% (24/25) | 4% (1/25) | Y |
| Patrick ( | N | Müller et al. ( | 88% (15/17) | 12% (2/17) | N |
| Pujara and Koenigs ( | N | Boccardi et al. ( | 98% (41/42) | 2% (1/42) | N |
| Stratton et al. ( | N | Contreras-Rodríguez et al. ( | 100% (42/42) | 0% (0/42) | Y |
| Umbach et al. ( | N | Yang et al. ( | 86% (18/21) | 14% (3/21) | Y |
| Lushing et al. ( | N | Boccardi et al. ( | 96% (52/54) | 4% (2/54) | Y |
| Santana ( | S | Tiihonen et al. ( | 91% (86/95) | 9% (9/95) | N |
| Smith et al. ( | T | Boccardi et al. ( | 100% (14/14) | 0% (0/14) | Y |
| Ortega-Escobar et al. ( | T | Gregory et al. ( | 100% (20/20) | 0% (0/20) | Y |
| Gao ( | N | Raine et al. ( | 90% (37/41) | 10% (4/41) | N |
| Ling and Raine ( | T | Yang et al. ( | 91% (21/23) | 9% (2/23) | Y |
| Ling et al. ( | T | de Oliveira-Souza et al. ( | 92% (48/52) | 8% (4/52) | N |
| Murray et al. ( | N | Ermer et al. ( | 100% (7/7) | 0% (0/7) | N |
| Pujol et al. ( | N | Yang et al. ( | 92% (82/89) | 8% (7/89) | N |
| Yang and Raine ( | N | Yang et al. ( | 96% (48/50) | 4% (2/50) | Y |
| Moreira et al. ( | S | Gregory et al. ( | 100% (9/9) | 0% (0/9) | N |
| Raine ( | T | Glenn et al. ( | 100% (4/4) | 0% (0/4) | Y |
| Blair and Zhang ( | T | Crooks et al. ( | 100% (3/3) | 0% (0/3) | N |
| Johanson et al. ( | S | Boccardi et al. ( | 96% (78/81) | 4% (3/81) | N |
| 91.01% (911/1001) | 8.99% (90/1001) | Y 33% (15/45) N 67% (30/45) | |||
C, comprehensive; E, editorial; M, meta-analysis; N, narrative (including reviews described as “critical”); S, systematic; T, targeted/focused.
Figure 2Null sMRI findings reported over time.
Null sMRI findings reported over time.
| 2005 and earlier | Original sMRI | 71 | 60 (84.51%) | 11 (15.49%) |
| Theoretical reviews | 11 | 4 (36.36%) | 7 (63.64%) | |
| Applied reviews | 0 | 0 | 0 | |
| 2006–2010 | Original sMRI | 102 | 76 (74.51%) | 26 (25.49%) |
| Theoretical reviews | 126 | 31 (26.72%) | 85 (73.28%) | |
| Applied reviews | 38 | 8 (21.05%) | 30 (78.95%) | |
| 2011–2015 | Original sMRI | 477 | 303 (63.52%) | 174 (36.48%) |
| Theoretical reviews | 165 | 11 (6.67%) | 154 (93.33%) | |
| Applied reviews | 131 | 4 (3.05%) | 127 (96.95%) | |
| 2016–2020 | Original sMRI | 33 | 20 (60.61%) | 13 (39.39%) |
| Theoretical reviews | 377 | 27 (7.16%) | 350 (92.84%) | |
| Applied reviews | 165 | 6 (3.64%) | 159 (96.36%) |